# OnCo record bayer (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/bayer/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "bayer" ;
  schema:name "Bayer"@en ;
  schema:description "Bayer owns Xofigo, the only approved alpha emitter, and is developing next-generation actinium PSMA agents."@en ;
  schema:url <https://onco.cc/companies/bayer/>, <https://www.bayer.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bayer> ;
  owl:sameAs <http://www.wikidata.org/entity/Q152051> ;
  schema:citation <https://www.bayer.com> ;
  schema:addressCountry "DE" ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/ac225-psma/> ;
  onco:companies <https://onco.cc/companies/leaps-by-bayer/> ;
  onco:trials <https://onco.cc/trials/nct06452277/>, <https://onco.cc/trials/nct05794906/>, <https://onco.cc/trials/nct07450599/>, <https://onco.cc/trials/nct04464226/>, <https://onco.cc/trials/nct06246643/>, <https://onco.cc/trials/nct06914128/>, <https://onco.cc/trials/nct06760819/>, <https://onco.cc/trials/nct05587296/>, <https://onco.cc/trials/nct02637687/>, <https://onco.cc/trials/nct07811193/> .